CFTR, the cystic fibrosis (CF) gene, encodes for the CFTR protein that plays an essential role in anion regulation and tissue homeostasis of various epithelia. In the gastrointestinal (GI) tract CFTR promotes chloride and bicarbonate secretion, playing an essential role in ion and acid-base homeostasis. Cftr has been identified as a candidate driver gene for colorectal cancer (CRC) in several Sleeping Beauty DNA transposon-based forward genetic screens in mice. Further, recent epidemiological and clinical studies indicate that CF patients are at high risk for developing tumors in the colon. To investigate the effects of CFTR dysregulation on GI cancer, we generated Apc Min mice that carried an intestinal-specific knockout of Cftr. Our results indicate that Cftr is a tumor suppressor gene in the intestinal tract as Cftr mutant mice developed significantly more tumors in the colon and the entire small intestine. In Apc +/+ mice aged to~1 year, Cftr deficiency alone caused the development of intestinal tumors in 460% of mice. Colon organoid formation was significantly increased in organoids created from Cftr mutant mice compared with wild-type controls, suggesting a potential role of Cftr in regulating the intestinal stem cell compartment. Microarray data from the Cftrdeficient colon and the small intestine identified dysregulated genes that belong to groups of immune response, ion channel, intestinal stem cell and other growth signaling regulators. These associated clusters of genes were confirmed by pathway analysis using Ingenuity Pathway Analysis and gene set enrichment analysis (GSEA). We also conducted RNA Seq analysis of tumors from Apc +/+ Cftr knockout mice and identified sets of genes dysregulated in tumors including altered Wnt β-catenin target genes. Finally we analyzed expression of CFTR in early stage human CRC patients stratified by risk of recurrence and found that loss of expression of CFTR was significantly associated with poor disease-free survival.
INTRODUCTION
CFTR, a cyclic adenosine monophosphate-regulated anion channel, is expressed at high levels in various epithelia, including the mucosa of the intestinal tract. CFTR protein is expressed in the apical membrane of enterocytes where it acts as the dominant ion channel transporter in the intestinal crypt epithelium. Essential functions of CFTR include chloride and bicarbonate secretion, and maintenance of fluid homeostasis. 1 Within the small intestine, CFTR expression is the strongest in the duodenum, including high expression in the mucus and bicarbonate-secreting Brunner's glands. 1 In the large intestine, CFTR expression is considered moderate. Along the crypt-villi axis, CFTR expression is highest in the crypts of the small intestine and near the crypt bases of the large intestine. Mutations in the CFTR gene are causative for cystic fibrosis (CF), 2 the most common autosomal recessive disorder in Caucasians. CF patients develop a range of dysfunctions in the gastrointestinal (GI) tract, including deficient anion (Cl − and HCO 3 − ) and fluid transport; altered cellular pH; an altered luminal environment with impaired secretion, release and clearance of mucus leading to meconium ileus and obstruction in the distal ileum and proximal large intestine; and abnormal bacterial colonization, microbial dysbiosis and abnormal innate immune responses that lead to chronic inflammation. 1 Downregulated expression and function of ion channels and transporters is observed in virtually all cancers. 3 Thus, with its highly important role in the normal physiology of various organs such as the GI tract, disruption of CFTR function and/or dysregulation of CFTR expression is associated with a wide array of cancers including esophageal, breast, gastric, hepatobiliary, gall bladder, prostate, pancreatic, small intestine and colorectal cancers (CRC). [4] [5] [6] [7] [8] [9] [10] [11] Furthermore, a 20-year study in CF patients revealed an increased risk of digestive tract cancers, with large numbers of cancers detected in the small intestine, colon and biliary tract. 6 Downregulation of CFTR mRNA gene expression was also included in a prognostic predictor gene set for poor diseasefree survival (DFS) in CRC. 12 Finally, in a recent study conducted at the University of Minnesota early colon screening of adult CF patients revealed a high incidence of colon tumors, especially in males. 13 Mouse models of Cftr deficiency have proven invaluable in understanding the role of CFTR in the normal physiology of the GI tract and in disease pathogenesis as human CF patients and Cftr fl/fl -Villin-Cre knockout mice share very similar intestinal disease pathophysiology. 14 In studies of CRC, Cftr was identified as a common insertion site candidate GI tract cancer gene in multiple Sleeping Beauty (SB) DNA transposon-based forward mutagenesis screens in mouse intestine. In an Apc wild-type screen, Cftr mutations were found in eight tumors (6%) 15 where SB transposon insertions were found in both the forward and reverse strand orientation, consistent with a well-accepted model that the SB transposon acts to disrupt function of the gene (Supplementary Figure S1 ). An SB screen on the Apc Min background found Cftr mutations in 102 tumors (23%), ranking it #70 of 641 common insertion site genes. 16 Most recently, Cftr was identified as a common insertion site gene in a set of SB screens in Apc-, SMAD4-and p53-deficient mice. 17 Finally, an SB screen in a p53 R27OH mutant background identified Cftr mutations in 12 tumors (20%) (TK Starr, personal communication).
To confirm the role of CFTR in GI cancer we examined CFTR deficiency in targeted mouse models and in human CRC patients. We measured GI cancer phenotypes in Apc Min mice carrying an intestinal-specific knockout of Cftr. We also examined the tumor phenotype of Apc +/+ Cftr fl/fl -Villin-Cre mice that were aged to~1 year. We performed global gene expression profiling using RNA isolated from normal colon and small intestine of Cftr -Villin-Cre mice. We identified gene sets and potential signaling pathways associated with the loss of Cftr. Finally, we examined the correlation between CFTR mutations and maintenance of CFTR expression and DFS in CRC patients.
RESULTS

Lethality phenotype of Cftr mutant mice
The intestinal-specific conditional Cftr knockout mice employed in our study 18 exhibited phenotypes previously attributed to Cftr constitutive and intestinal-specific knockout mice, 19, 20 including inflammation in the proximal large intestine, reduced growth and body weight, and perinatal lethality due to intestinal obstruction caused by mucus accumulation. 14, 18, 21 These phenotypes were strongest in male mice. Less than 15% of the expected Cftr fl/fl -Villin-Cre mice were observed at weaning, and survival of these mice post-weaning was only made possible by the addition of an oral osmotic laxative to the drinking water, resulting in 450% survival, which is significantly higher than in Cftr constitutive knockout mice. Cftr fl/fl -Villin-Cre mice aged to~1 year also exhibited increased length and size of the distal small intestine as has been observed previously. Cftr wild-type mice. This phenotype was observed in both Cftr heterozygous and Cftr homozygous mutants, with the tumor phenotype strongest in Cftr homozygous mutants. The increase in tumor multiplicity occurred in both the small intestine (SI) and the colon ( Table 1) -Villin-Cre mice to 12 months, we found that loss of Cftr alone could induce tumor formation in both the colon and small intestine, with a penetrance 460% (multiplicity 1.6; Table 2 ), compared with zero tumor incidence in control mice. Representative intestinal tumors were examined by light microscopy; in all cases they were diagnosed as adenomas with occasional microadenomas (Figure 2 ). These tumors were found throughout the intestinal tract with the highest number found in the proximal SI. -Villin-Cre. All mice were on the C57BL/6 genetic background. SI-1 through SI-4 represent four equal sized segments of the small intestine, proximal to distal, with SI-1 containing the duodenum and proximal jejunum, SI-2 containing the remainder of the jejunum, and SI-3 and SI-4 containing the ileum. -Villin-Cre mice were killed at 120 days of age or when moribund and tumors were counted in formalin-fixed tissues.
than 100 genes that showed a 41.5-fold change in expression (with a P-value o0.05) in the SI and 58 in the colon. The top upand downregulated genes are listed in Table 3 (SI) and Table 4 (colon) (see Supplementary Table S1 for full list). Expression of 12 of these genes, from both SI (Figure 3a ) and colon (Figure 3b) , was confirmed by reverse transcriptase-PCR. Among top gene clusters identified are immune cell homeostasis (Reg3g, Reg3b), mucins, inflammation (Retnlb, S100A11), growth regulation and cell signaling (Areg), migration and invasion, lipid metabolism, stress response and detoxification (nine cytochrome p450 genes), water homeostasis (Aqp4) and stem cell regulation (Aldh1a1, Phlda1). Ingenuity Pathway Analysis (IPA) on the microarray data sets of normal SI and colon in wild-type and Cftr-deficient samples identified several major networks. In the SI these include genes involved in drug metabolism-small-molecule biochemistry-lipid C57BL/6-Apc +/+ Cftr fl/fl -Villin-Cre + mice and a contemporaneous control set of C57BL/6 Cftr wild-type mice, of roughly equal numbers by gender, were aged tõ 1 year, then killed. Tumors were counted in formalin-fixed tissues from throughout the intestinal tract using a dissecting microscope. A subset of tumors was removed fresh frozen for RNA analysis and another subset was removed as formalin-fixed tissues for histopathological and immunohistochemical analysis. As has been observed before, no tumors were found in C57BL/6 Cftr wild-type control mice. Figures S2A and B) . In the colon, major networks included molecular transport-lipid metabolism-smallmolecule biochemistry and cellular growth/proliferation-renal and urological system development and function (Supplementary Figures S2C and D) . Among top biological functional groups are altered genes that play important roles in immune trafficking. We have previously reported functional overlap between the ion channel genes Cftr and Kcnq1 in the intestinal crypt. 22 In our current analysis, gene set enrichment analysis (GSEA) of microarray data from normal colon and normal SI showed overlapping changes in gene expression in Kcnq1 and Cftr-deficient mice (Supplementary Figures S3A and B) . Moreover, GSEA also showed overlap between both Cftr and Kcnq1 in the Mucin 2 protective -Villin-Cre and Cftr +/+ mice. mRNAs were isolated from 1 cm sections of the proximal small intestine from the same region for all mice. Villi were removed from the tissue prior to processing. Four replicates of each assay were performed for each matched pair of mRNAs and these sets of assays were repeated at least two times for each pair of mRNAs. At least two matched pairs of mRNAs were tested for each gene with most genes tested in at least three matched pairs of mRNAs. To be included in this figure genes met the flowing criteria: (1) the mean fold difference was at least 1.5; and (2) each gene showed a change in gene expression in the same direction in each matched pair of mRNAs. In all cases the direction of changes in gene expression confirmed microarray data. *P o0.05. (b) qRT-PCR gene expression analysis of mouse normal colon of Apc +/+ Cftr fl/fl -Villin-Cre mice. Samples were analyzed in triplicate and normalized to 18S ribosomal RNA. Data are presented as the mean fold change ± s.d. Each bar represents the mean and s.e. of multiple experiments that measured fold differences in the mRNA expression of whole colon tissue isolated from adult (~100 days), littermate and gender matched pairs of Apc +/+ Cftr fl/fl -Villin-Cre and Cftr +/+ mice. RNA was isolated from 1 cm sections from the same region of distal colon. Four replicates of each assay were performed for each matched pair of mRNAs and these sets of assays were repeated at least two times. At least two matched pairs of mRNAs were tested for each gene with most genes tested in at least three matched pairs of mRNAs. To be included in this figure genes met the flowing criteria: (1) the mean fold difference was at least 1.5; and (2) each gene showed a change in gene expression in the same direction in each matched pair of mRNAs. In all cases the direction in changes in gene expression confirmed microarray data. *Po 0.05. Figure S3C) as gene expression changes in Kcnq1 and Cftr-deficient mice overlap with those in Muc2 deficient mice. -Villin-Cre mice we conducted immunohistochemistry and found upregulation of cytoplasmic β-catenin and enhanced nuclear localization (Supplementary Figure S8) . Finally, IPA analysis was conducted to compare changes in gene expression in Cftrdeficient tumors and Cftr-deficient normal tissues to identify overlapping pathways that are further activated in tumors. Significant overlap was observed in the LXR/RXR (lipid metabolism) and toll-like receptor (innate immune response) pathways, with the strongest Z-scores linked to genes involved in NF-κB inflammatory responses, including members of the IL1β and its receptor family (Il1β, I1rl1, Il1rrn, St2l), Ptgs2 and Tnfrsr11B (an upstream activator of NF-κB) (Supplementary Figures S9A and B) .
pathway (Supplementary
Low CFTR expression is associated with poor DFS in CRC patients We analyzed DFS in a set of stage II CRC samples (AMC-AJCCII-90), 27 stratified by CFTR-high and CFTR-low mRNA expression. The Kaplan-Meier analysis and log-rank test were used to correlate CFTR expression with DFS. We found that in the complete AMC90 set the 3-year relapse free survival was 85% in the CFTR high-expressing group compared with 56% in the CFTR low-expressing group (P = 0.02, log-rank test; Figure 4a ). Moreover, in the MSS subset the 3-year survival was 85% in the CFTR highexpressing group compared with 38% in the CFTR low-expressing group (P = 0.002, log-rank test) (Figure 4b ). In addition, the multivariate analysis showed that CFTR expression is an independent prognostic determinant (Table 5) . Further, based on the mouse tumor pathway analyses, we examined the expression levels of several genes involved in inflammatory/innate response pathways in the CFTR low-expressing group and found a significant correlation with higher levels of IL1β, XBP1 and NFKB2 in the CFTR low tumors, similar to that observed in the mouse tumors (Supplementary Figure S10) .
DISCUSSION
Several overlapping phenomena related to the pathophysiology of CFTR deficiency in the GI tract have been proposed to explain the susceptibility to CRC. Foremost is the inflammatory landscape Figure 4 . Kaplan-Meier estimate of disease-free survival (DFS) in the AMC-AJCCII-90 set between CFTR low and CFTR high-expressing tumors. Disease-free survival within the AMC-AJCCII-90 set stratified by CFTR expression of the tumor in the complete set (a) and in the MSS subset (b). The 3-year disease-free survival for the complete set (a) was 85% in the CFTR high group and 56% in the CFTR low group. In the MSS set (b) the 3-year disease-free survival was 85 and 38% in the CFTR high group and CFTR low group, respectively. P-values are based on log-rank test. The univariate and multivariate analysis both show that CFTR expression is an important prognostic determinant in the AMC-AJCCII-set.
in the GI tract observed in CF patients, a phenotype that is modeled well in Cftr intestinal-specific knockout mice. In both human CF patients and Cftr knockout mice there is impaired mucosal barrier function, including disrupted tight junctions, 28 that leads to compromised resistance to bacterial colonization, 29 infection, and abnormal innate and adaptive immune responses and inflammation, factors that together may promote oncogenesis. 1, 21, 30, 31 Increased epithelial permeability is also a major factor in bicarbonate loss in the inflamed colon. 32 At the molecular level, CFTR has been reported to be a negative regulator of the proinflammatory NFKB-mediated innate immune responses, including IL8, 33 and the COX2-PGE 2 positive feedback loop in inflammation. 34 Consistent with this, our microarray studies in normal mouse SI and colon, along with IPA and GSEA pathway analyses, showed dysregulation of signaling pathways involving immune mediation and inflammation. RNA Seq analyses of Cftr-deficient intestinal tumors confirmed an altered proinflammatory gene expression profile in both normal Cftr-deficient tissues and in Cftr-deficient tumors. An example are the numerous members of the S100A gene family found to be upregulated, including S100A4, − A6, − A9, − A11, − A14 and − A16, all genes associated with inflammation and progression of human cancers. Another example is the 13-fold increase in expression of the proinflammatory oncogenic Ptgs2 gene (Supplementary Table S12 ). Finally, Cftr deficiency in tumors caused the upregulation of numerous proinflammatory chemokines, cytokines and their receptors, and members of the NF-kB signaling pathway. Examples included several CCL chemokines (e.g., CCL2 (MCP-1)), five CXC chemokine receptors and their ligands, four CCR chemokine receptors (e.g., CCR5), eight members of the TNF family, three toll-like receptor (TLR) genes and the Rel transcription factor (Supplementary Table S2 ).
Previous studies in KO mice found an overlap in gene sets from Cftr, Kcnq1 and Muc2 deficient mice. 22 This was confirmed by GSEA ( Supplementary Figures S3A and B) of normal Cftr fl/fl -VillinCre tissues. For example, several members of the regenerating islet-derived gene (Reg3) family, which are involved in innate immune responses in the intestinal tract, were dysregulated in all three KO mouse models 22, 35 (and Tables 3 and 4 ). CFTR and KCNQ1 closely cooperate in maintaining ion and fluid homeostasis in the intestine, thereby facilitating proper processing of MUC2, and preventing mucus dehydration and related mucus plugging, intestinal obstruction and resultant inflammation. In particular, mucus and Muc2 are important for immunomodulatory signaling. 36 In Cftr knockout mice Muc2 protein is secreted but remains attached to the epithelium, and thus unable to form a mucus gel. This defect is proposed to be due to poor mucus folding caused by the absence of bicarbonate. 14, 37, 38 Therefore, regulation of chloride and bicarbonate secretion is critical to intestinal homeostasis. Chloride secretion is a complex mechanism that involves several ion transporters, including K + and Cl − channels. Potassium ion recycling, via KCNQ1, across the basolateral membrane is the electrochemical driving force for Cl − to be secreted across the apical membrane through CFTR. Chloride secretion in turn also identifies CFTR and KCNQ1 as important regulators of water homeostasis. Aquaporins are water channels that play very important roles in normal intestinal function and several water channel genes, including aquaporins (Aqp1, Aqp4), were found to be dysregulated in microarray studies in Table S1 ). Notably, Aqp4 was found to be significantly downregulated (by 85%) in tumors arising in Apc +/+ Cftr fl/fl -Villin-Cre mice (Supplementary Table S13 ).
Both Kcnq1 (in situ hybridization 25 ) and Cftr (single-cell gene expression studies 39 ) have been implicated in regulation of the ISC compartment. For Cftr, single-cell analysis of colon cell heterogeneity reported that Cftr was part of a gene signature for a stem/progenitor cell subset of EpCAM high /CD44+ cells that was Lgr5+/Ascl2+ and which also included Aqp1. 39 Figure S5) . How CFTR may alter ISC dynamics is unknown but there is strong evidence that the microenvironment is a key regulator of ISCs, including their capacity for malignant transformation. 40, 41 Model of Cftr-deficient tumorigenesis Tumors that developed in Apc +/+ Cftr fl/fl -Villin-Cre mice were found to express elevated levels of Wnt/β-catenin target genes indicating that CFTR-deficient tumors likely arise from activation of β-catenin. This finding was supported by GSEA of RNA Seq data from these tumors (Supplementary Figure S6) that found a significant overall enrichment for genes dysregulated in Apc Min Cftr +/+ tumors, in particular in Wnt target genes (Supplementary Figure S7) and upregulation of cytoplasmic and nuclear β-catenin in the tumors (Supplementary Figure S8) . Accordingly, a model for tumor development in both humans and mice deficient for CFTR would include long-term chronic inflammation associated with microbial dysbiosis, leading to altered innate (Supplementary Figures S9 and S10 ) and adaptive immune responses, and dysregulation of the stem cell compartment. Loss of CFTR may cooperate with defects in other ion channels genes, ultimately leading to activation of β-catenin. This model is similar to that proposed for tumor development in AOM-DSS-treated mice, which is also characterized by chronic inflammation and activation of β-catenin.
The identification of CFTR as a prognostic predictor of DFS in CRC patients is fully consistent with epidemiological 6,7 and clinical 13 data indicating that CF patients are at an increased risk for CRC. Our finding of a correlation between CFTR mRNA expression and DFS for CRC is also consistent with at least one other study that included downregulation of CFTR expression in a prognostic predictor set for CRC. 12 It is also consistent with a report that CFTR was a signature gene and a biomarker for a type of transit amplifying CRC associated with good DFS. 42 It was also reported that CFTR expression was lower in the stem cell-like CRC subset and lowest in the inflammatory CRC class.
The data are also supportive of functional links between CFTR, KCNQ1 and MUC2 as both Kcnq1 and Muc2 have been shown to act as tumor suppressors in the GI tract of mice, 22, 43, 44 similar to Cftr. Notably, maintenance of KCNQ1 protein expression is associated with increased DFS in stage IV CRC patients, 22 like CFTR, and KCNQ1 mRNA and protein expression is associated with DFS in stage II and III CRC patients (RJA Fijneman and L Vermeulen, personal communication).
The stratification of human CRCs into high and low expression of CFTR in our study is consistent with potential epigenetic silencing of CFTR in these cancers, which is supported by reports that the promoter of CFTR is GC rich and that CFTR is frequently hypermethylated in both cancer cell lines (promyelocytic leukemia) 45 and primary non-small-cell lung cancer samples. 46 It is important to note that~4% of the Caucasian population carry CFTR mutations. Therefore, epigenetic silencing could be one means for LOH at the CFTR locus.
Therapies under development to treat complications in the GI tract of CF patients, such as correctors and potentiators, may be effective in preventing or treating GI tract cancers. 3, 47, 48 Further studies to understand the mechanisms underlying CFTR's tumor resistance can lead to its application in the clinic as a prognostic predictor and therapeutic target in CRC. Tumor multiplicity analysis Scoring of formalin-fixed intestinal tumor tissues blinded to genotype was performed as previously described. 50 Two-sided P-values for tumor counts were determined by use of the Wilcoxon rank sum test comparing gender and age-matched classes produced in the same genetic crosses.
MATERIALS AND METHODS
Histopathology
Histopathological analysis of tumors and adjoining normal tissue was performed on tissues that were fixed in 10% neutral buffered formalin, routinely processed into paraffin, sectioned at a thickness of 4 μm, stained with hematoxylin and eosin and examined using light microscopy. All tissues were analyzed blind to the genotype of the samples by an A.C.V.P.-certified veterinary pathologist (MGO'S) from the University of Minnesota Masonic Cancer Comparative Pathology Shared Resources facility, and using the standardized nomenclature of the 2003 Consensus Report and Recommendations for pathology of mouse models of intestinal cancer as published. 50, 51 Immunohistochemistry for β-catenin Four-micrometer formalin-fixed, paraffin-embedded sections of small intestine tumors were deparaffinized and rehydrated, followed by antigen retrieval using 10 mM Citrate buffer pH 6.0 in a steamer. Immunohistochemistry for ß-catenin was performed on a Dako Autostainer using a rabbit anti-human ß-catenin monoclonal antibody (Abcam, Cambridge, MA, USA; catalog # AB32572) as primary antibody (after blocking endogenous peroxidase and application of a protein block). Detection was achieved using a rabbit EnVision+ Kit (catalog K4011; Dako, Carpinteria, CA, USA) with diaminobenzidine (Dako) as the chromogen. Mayer's hematoxylin (Dako) was used as the counterstain. Small intestinal adenomas from Apc Min mice were used as a positive control tissue, and for negative control slides the primary antibody was substituted with Negative Control Rabbit IgG (Biocare, Tempe, AZ, USA).
Epithelial RNA processing for illumina bead arrays Mouse SI and colon tissues were opened longitudinally, and rinsed in phosphate-buffered saline. For the SI, villi were removed from the distal quarter of the proximal quarter, and tissue was then flash frozen in liquid nitrogen. Tissue was transferred from liquid nitrogen to pre-cooled RNALaterIce (Ambion/Life Technologies, Grand Island, NY, USA) at − 80°C for 30 min, and then was transferred to − 20°C for at least 48 h. Immediately before RNA isolation, tissue in either RNALater or RNALaterIce was placed in 2-4 ml of RLT/14.3 M β-mercaptoethanol buffer. Tissue was then homogenized using an IKA Ultra-Turrax T25 digital homogenizer (Fisher Scientific, Pittsburgh, PA, USA). RNA isolation was then conducted using an RNeasy Mini Kit with an additional DNAse Digestion step (Qiagen, Valencia, CA, USA). For the colon, epithelial RNA processing and isolation were performed as previously described. 49 RNA sample concentrations were measured using a Nanodrop-1000 Spectrophotometer (Thermo Scientific, Waltham, MA, USA). RNA was stored at − 80°C.
Illumina bead microarray and data analysis RNA labeling, microarray hybridization and scanning were performed at the University of Minnesota Genomics Center using Illumina MouseWG-6 v2.0 Expression BeadChips (Illumina, San Diego, CA, USA), according to the manufacturer's instructions. Differential expression of genes was quantified by the moderated t-statistic. The BeadArray data was processed via R/ Bioconductor and packages lumi and limma. Background-corrected log2-transformed data was normalized via quantile normalization from the lumi package. Data were further analyzed using GeneData Expressionist Software (GeneData Inc., San Francisco, CA, USA); genes that showed statistically significant differences in expression between groups were determined using the two-group test t-test and analysis of variance. Gene expression data have been submitted to the Gene Expression Omnibus (GEO), Accession number SuperSeries GSE76096 SubSeries GSE75996.
Quantitative reverse transcriptase-PCR
Quantitative reverse transcriptase-PCR was performed as previously described. 22 Significant differences in expression between groups were determined using the two-group t-test.
List of primers used
All primers were designed using Primer-BLAST (National Center for Biotechnology Information) and obtained from Integrated DNA Technologies (Coralville, IA, USA).
Forward
Reverse
RNA Seq RNA Seq was performed at the UMGC as described previously. 22 The extracted RNA samples were sequenced using the Illumina HiSeq 2500 platform, v.4 SBS chemistry, 125 bp paired-end reads. All raw reads that passed the CASAVA 1.8P/F filter were directly deposited at the Minnesota Supercomputing Institute, where the data were analyzed. Sequence quality was assessed via fastqc (http://www.bioinformatics.babraham.ac.uk/projects/ fastqc/). Since the raw sequence reads were of sufficient quality, no data trimming or filtering was necessary. Hence, the raw paired-end reads were mapped to mouse genome (mm10 assembly) using Tophat 2.0.13 with the iGenomes reference (UCSC mouse mm10 annotation, downloaded from http://cufflinks.cbcb.umd.edu/igenomes.html). Final mapping percentages of the samples range from 89 to 93%. The mapped samples were then analyzed via Cuffdiff 2.2.1 (default parameters using the iGenomes UCSC mm10 GTF file previously mentioned) to quantify the expression level of each known gene in units of FPKM (Fragment mapped per kilobase of exons per million mapped reads). In order to minimize the potential confounding factors, cuffdiff analysis was only carried out between sample pairs that were prepared and sequenced in batches. The results were all ranked by the absolute value of fold. Gene expression data have been submitted to the Gene Expression Omnibus (GEO), Accession number SuperSeries GSE76096 SubSeries GSE76095. Figure S9 ) changes in expression were analyzed using IPA. 52 GSEA: GSEA v. 2.0, http://www.broad.mit.edu.gsea/. 53 Default parameters were used except that gene-set permutation was used due to the small number of samples.
Pathway analysis
Bead Array: GSEA compared the entire ranked Cftr fl/fl -Villin-Cre gene expression data sets from the normal colon and proximal small intestine to gene signatures derived from Kcnq1 KO SI and colon 22 and from Muc2 KO SI. 43 RNA Seq: Entire ranked gene expression data sets comparing indicated Cftr-deficient tissues were compared with published gene signatures for ISC and WNT target genes, 24, 26 
